Teacher Retirement System of Texas Acquires 37,107 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Teacher Retirement System of Texas boosted its stake in HCA by 80.1% in Q4, acquiring 37,107 shares to hold 83,427 shares worth about $38.95 million.
• HCA beat quarterly EPS estimates with $8.01 (vs. $7.37 expected) and reported revenue of $19.51 billion (down slightly vs. expectations), while setting FY2026 guidance of 29.100–31.500 EPS (analysts average ~30.17 EPS).
• HCA raised its quarterly dividend to $0.78 (annualized $3.12, ~0.7% yield), and Wall Street consensus is a “Moderate Buy” with an average price target of $537.36.

Teacher Retirement System of Texas grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 80.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 83,427 shares of the company's stock after acquiring an additional 37,107 shares during the period. Teacher Retirement System of Texas' holdings in HCA Healthcare were worth $38,949,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of HCA. Palisade Asset Management LLC bought a new position in HCA Healthcare during the third quarter valued at about $26,000. Holos Integrated Wealth LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at about $29,000. Harbor Capital Advisors Inc. grew its position in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company's stock valued at $32,000 after purchasing an additional 34 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at about $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at about $34,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Up 0.6%

Shares of HCA Healthcare stock opened at $474.34 on Friday. The stock has a market capitalization of $106.05 billion, a price-to-earnings ratio of 16.71, a P/E/G ratio of 1.45 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $321.39 and a 1-year high of $556.52. The firm's 50-day moving average price is $507.59 and its two-hundred day moving average price is $485.06.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analysts' expectations of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company's quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 30.17 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were given a dividend of $0.78 per share. The ex-dividend date was Tuesday, March 17th. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.99%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on HCA. Robert W. Baird reduced their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a "neutral" rating for the company in a research note on Wednesday, April 15th. Sanford C. Bernstein set a $541.00 target price on shares of HCA Healthcare in a research note on Monday, February 9th. TD Cowen increased their target price on shares of HCA Healthcare from $529.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, March 10th. Weiss Ratings reiterated a "buy (b)" rating on shares of HCA Healthcare in a research note on Friday, March 27th. Finally, Wells Fargo & Company increased their price target on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an "equal weight" rating in a research report on Friday, January 30th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and an average price target of $537.36.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the company's stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jennifer Berres sold 8,020 shares of the company's stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last ninety days. Company insiders own 1.50% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.